NCT03693014 2025-10-06A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint InhibitorsMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting69 enrolled
NCT03289962 2025-07-04A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsGenentech, Inc.Phase 1 Completed272 enrolled
NCT04107168 2023-02-16Microbiome Immunotherapy Toxicity and Response EvaluationCambridge University Hospitals NHS Foundation TrustUnknown1,800 enrolled
NCT02543645 2018-04-30A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerCelldex TherapeuticsPhase 1 Terminated18 enrolled